Drugs.com: Escitalopram reduces symptoms of anxiety in teens
Outlet covers UC research that points to a possible new treatment for adolescent anxiety
For adolescents with generalized anxiety disorder, UC research has shown that the medication escitalopram could reduce symptoms. The study was published online Aug. 25 in The Journal of Clinical Psychiatry.
Jeffrey Strawn, MD, associate professor and anxiety expert in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati, and colleagues treated adolescents with anxiety disorder with escitalopram or a placebo for eight weeks to see if improvement occurred.
"For clinicians treating anxious adolescents, this study provides preliminary answers to important questions about the effectiveness of this treatment," Strawn says.
Read the full Drugs.com story.
Psych Central also reported on this research.
Read the full UC News release.
Featured photo courtesy of Unsplash.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Boosting safety in proton therapy for kids
March 3, 2026
University of Cincinnati backed startup, Range Assure, aims to make pediatric proton therapy safer by reducing radiation uncertainty and protecting healthy tissue.
German TV highlights UC expert's ancient Maya discoveries
March 2, 2026
The German television show 'Unsolved Case' talks to a University of Cincinnati expert about ballcourts used by the ancient Maya for a program examining how people used spheres as both tools and toys.
UC studies supplement, therapy alternatives to treat depression
March 2, 2026
Media outlets including Cleveland.com and Cleveland's WKYC News highlighted a new University of Cincinnati clinical trial funded by an approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to test two new nonpharmacological treatments for teens and young adults with depression.